No CrossRef data available.
Article contents
The global spread of clinical trials
Published online by Cambridge University Press: 02 January 2018
Extract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
There has been considerable publicity recently in the UK concerning the threatened contraction of the country's pharmaceutical industry. The UK currently has the third highest share of global pharmaceutical research and development expenditure (after the USA and Japan), but the costs of conducting research in the UK are rising.
- Type
- Thematic Papers
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
- Copyright
- Copyright © Royal College of Psychiatrists 2012
References
Academy of Medical Sciences (2011) A New Pathway for the Regulation and Governance of Health Research. Academy of Medical Sciences.Google Scholar
Reuters (2011) Special report: Big Pharma's global guinea pigs, 6 May. Available at http://www.reuters.com/article/2011/05/06/us-pharmaceuticals-trials-idUSTRE7450SV20110506 (accessed March 2012).Google Scholar
You have
Access
Open access
eLetters
No eLetters have been published for this article.